Strumento inattivo

Azioni WuXi PharmaTech (Cayman) Inc. (ADR)

Azioni

Prezzo di chiusura Nyse Altri mercati azionari
- ^USD	-

WuXi PharmaTech Cayman : LabNetwork Forges eCommerce Alliances with Leading Chemical Providers	27/04/16
WuXi PharmaTech Cayman : AppTec Congratulates MSD on Receiving FDA Approval of Zepatier	05/02/16
WuXi PharmaTech Cayman : AppTec Congratulates Chia Tai Tianqing Pharmaceutical Group and Janssen for Licensing Agreement	12/01/16
WuXi PharmaTech Cayman : AppTec Plans $120 Million Investment in New Integrated Biologics Solution Center to Expedite Biologics Development from Ideas to Clinic	12/01/16
WuXi PharmaTech Cayman : and AstraZeneca Form Strategic Alliance to Expedite Development of AstraZeneca's Innovative Biologics Portfolio in China	16/12/15

Dirigenti	Titolo	Età	Da
Xiao Zhong Liu FOU	Founder	60	01/01/00
Zhao Hui Zhang FOU	Founder	54	01/01/00
Ge Li CEO	Chief Executive Officer	56	01/01/00

Amministratori	Titolo	Età	Da
Ge Li CEO	Chief Executive Officer	56	01/01/00
Zhao Hui Zhang FOU	Founder	54	01/01/00
Xiao Zhong Liu FOU	Founder	60	01/01/00

Settore

	Variaz. 1 gen.	Capi.
IQVIA HOLDINGS INC.	-1,82%	41,35 Mrd
LONZA GROUP AG	+44,25%	40,38 Mrd
MODERNA, INC.	+2,56%	39,05 Mrd
CELLTRION, INC.	-12,11%	26,67 Mrd
ICON PUBLIC LIMITED COMPANY	+3,09%	24,07 Mrd
ALNYLAM PHARMACEUTICALS, INC.	-24,16%	18,36 Mrd
MEDPACE HOLDINGS, INC.	+22,12%	11,6 Mrd
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,74%	11,68 Mrd
UNITED THERAPEUTICS CORPORATION	+7,75%	11,15 Mrd